Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SUPV
2501
Grupo Supervielle
SUPV
$705M
| $867K | ﹤0.01% |
213,598
-331,103
| -61% | -$903K |
|
2502
Instil Bio
TIL
$50.1M
| $866K | ﹤0.01% |
113,614
+61,343
| +117% | +$444K |
|
|
RERE
2503
ATRenew
RERE
$1.01B
| $865K | ﹤0.01% |
450,500
+282,700
| +168% | +$496K |
|
2504
KT
KT
$9.11B
| $864K | ﹤0.01% |
+64,293
| New | +$823K |
|
2505
Sportradar
SRAD
$4.09B
| $863K | ﹤0.01% |
78,100
-1,992
| -2% | -$19.6K |
|
2506
Moog Inc Class B
MOG.B
| $856K | ﹤0.01% |
5,900
| – | – |
|
2507
Quaker Houghton
KWR
$2.94B
| $854K | ﹤0.01% |
+4,000
| New | +$689K |
|
2508
Vroom Inc
VRM
$56.8M
| $854K | ﹤0.01% |
17,713
-22,463
| -56% | -$1.47M |
|
2509
Super Micro Computer
SMCI
$25.8B
| $853K | ﹤0.01% |
+30,000
| New | +$832K |
|
2510
Timken Company
TKR
$9.25B
| $850K | ﹤0.01% |
10,600
-109,700
| -91% | -$8.07M |
|
2511
Vanguard FTSE Pacific ETF
VPL
$8.64B
| $850K | ﹤0.01% |
+11,800
| New | +$801K |
|
2512
Green Dot
GDOT
$771M
| $849K | ﹤0.01% |
+85,722
| New | +$893K |
|
2513
Pixelworks
PXLW
$44.4M
| $849K | ﹤0.01% |
54,000
+10,317
| +24% | +$150K |
|
|
MCHB
2514
Mechanics Bancorp
MCHB
$3.78B
| $848K | ﹤0.01% |
82,300
-1,800
| -2% | -$12.4K |
|
2515
BCE
BCE
$21.9B
| $845K | ﹤0.01% |
21,400
-604,360
| -97% | -$23.4M |
|
2516
Digimarc Corp
DMRC
$169M
| $845K | ﹤0.01% |
23,408
+9,908
| +73% | +$314K |
|
2517
YieldMax TSLA Option Income Strategy ETF
TSLY
$674M
| $845K | ﹤0.01% |
7,080
-18,120
| -72% | -$2.19M |
|
2518
Urban One Class D
UONEK
$23.4M
| $845K | ﹤0.01% |
23,941
-520
| -2% | -$23.8K |
|
2519
Inspired Entertainment
INSE
$164M
| $844K | ﹤0.01% |
85,400
+64,500
| +309% | +$609K |
|
2520
Planet Labs
PL
$8.8B
| $841K | ﹤0.01% |
+340,400
| New | +$805K |
|
2521
Innovator US Equity Power Buffer ETF July
PJUL
$1.29B
| $839K | ﹤0.01% |
+23,183
| New | +$803K |
|
2522
Cannae Holdings
CNNE
$635M
| $837K | ﹤0.01% |
42,900
-61,800
| -59% | -$1.13M |
|
2523
Xtant Medical Holdings
XTNT
$42.8M
| $837K | ﹤0.01% |
740,910
+71,172
| +11% | +$83.7K |
|
2524
CubeSmart
CUBE
$9.34B
| $830K | ﹤0.01% |
+17,900
| New | +$703K |
|
2525
First Bank
FRBA
$471M
| $829K | ﹤0.01% |
56,388
+2,100
| +4% | +$26K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.